Terms: = Lung cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715 AND Prognosis
17 results:
1. The innovative checkpoint inhibitors of lung adenocarcinoma, cg09897064 methylation and ZBP1 expression reduction, have implications for macrophage polarization and tumor growth in lung cancer.
Wang A; Zheng WS; Luo Z; Bai L; Zhang S
J Transl Med; 2024 Feb; 22(1):173. PubMed ID: 38369516
[TBL] [Abstract] [Full Text] [Related]
2. cebpa facilitates LOXL2 and LOXL3 transcription to promote BCL-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro.
Fan L; Jiang W; Chen C; Gao H; Shi J; Wang D
Exp Cell Res; 2024 Feb; 435(2):113937. PubMed ID: 38242344
[TBL] [Abstract] [Full Text] [Related]
3. Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma.
Sui Q; Hu Z; Liang J; Lu T; Bian Y; Jin X; Li M; Huang Y; Yang H; Wang Q; Lin Z; Chen Z; Zhan C
Cancer Lett; 2024 Jan; 581():216497. PubMed ID: 38008395
[TBL] [Abstract] [Full Text] [Related]
4. CCAAT enhancer binding protein α suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt/β-catenin signaling.
Zhang LM; Li M; Tian CC; Wang TT; Mi SF
Neoplasma; 2021 May; 68(3):602-612. PubMed ID: 33780265
[TBL] [Abstract] [Full Text] [Related]
5. Non-myxoma neoplastic cerebral aneurysms: A systematic review.
Nussbaum ES; Torok CM; Khalil ZM; Pederson JM
J Clin Neurosci; 2020 Dec; 82(Pt B):200-206. PubMed ID: 33246908
[TBL] [Abstract] [Full Text] [Related]
6. Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer.
Li Y; Liu Y; Zhao N; Yang X; Li Y; Zhai F; Zang X; Cui W
Cell Death Dis; 2020 Sep; 11(9):753. PubMed ID: 32934224
[TBL] [Abstract] [Full Text] [Related]
7. When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
Roloff GW; Griffiths EA
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):35-44. PubMed ID: 30504289
[TBL] [Abstract] [Full Text] [Related]
8. When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
Roloff GW; Griffiths EA
Blood Adv; 2018 Nov; 2(21):3070-3080. PubMed ID: 30425072
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
[TBL] [Abstract] [Full Text] [Related]
10. The ratio of cancer cells to stroma within the invasive area is a histologic prognostic parameter of lung adenocarcinoma.
Ichikawa T; Aokage K; Sugano M; Miyoshi T; Kojima M; Fujii S; Kuwata T; Ochiai A; Suzuki K; Tsuboi M; Ishii G
Lung Cancer; 2018 Apr; 118():30-35. PubMed ID: 29571999
[TBL] [Abstract] [Full Text] [Related]
11. [Expression of phosphatase and tensin homology deleted on chromosometen (PTEN) in squamous-cell lung cancer and its clinical significance].
Li YN; Zhou YZ; Zhang N; Wang HW
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):450-3. PubMed ID: 27289574
[TBL] [Abstract] [Full Text] [Related]
12. Lower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell lung cancer.
Kinsey CM; San José Estépar R; van der Velden J; Cole BF; Christiani DC; Washko GR
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):38-43. PubMed ID: 27197281
[TBL] [Abstract] [Full Text] [Related]
13. Antitumor and Antimetastatic Activity of Synthetic Hydroxystilbenes Through Inhibition of Lymphangiogenesis and M2 Macrophage Differentiation of Tumor-associated Macrophages.
Kimura Y; Sumiyoshi M; Baba K
Anticancer Res; 2016 Jan; 36(1):137-48. PubMed ID: 26722037
[TBL] [Abstract] [Full Text] [Related]
14. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract] [Full Text] [Related]
15. The evolution of treatment for Wilms tumor.
Green DM
J Pediatr Surg; 2013 Jan; 48(1):14-9. PubMed ID: 23331787
[TBL] [Abstract] [Full Text] [Related]
16. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
Oncologist; 2012; 17(1):13. PubMed ID: 22210086
[TBL] [Abstract] [Full Text] [Related]
17. Up-regulation of osteopontin expression by aryl hydrocarbon receptor via both ligand-dependent and ligand-independent pathways in lung cancer.
Chuang CY; Chang H; Lin P; Sun SJ; Chen PH; Lin YY; Sheu GT; Ko JL; Hsu SL; Chang JT
Gene; 2012 Jan; 492(1):262-9. PubMed ID: 22037483
[TBL] [Abstract] [Full Text] [Related]
